Cover Image
市場調查報告書

全球和中國的DNA定序產業分析

Global and China DNA Sequencing Industry Research Report, 2014-2017

出版商 ResearchInChina 商品編碼 316187
出版日期 內容資訊 英文 85 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球和中國的DNA定序產業分析 Global and China DNA Sequencing Industry Research Report, 2014-2017
出版日期: 2014年10月13日 內容資訊: 英文 85 Pages
簡介

隨著DNA測序技術的進步和成本大幅度降低,預計DNA定序器的潛在市場規模今後將急速擴大,非侵入性偵測、疾病診斷、個人化醫療等領域也急速普及。全球DNA定序市場(設備、消耗品、相關服務、工作流程等)的規模,2013年為46億美元(與去年同期比較增加26%),預計2017年達到100億9600美元。現在,DNA測序技術發展到第4代,不過最新的第4代還在開發中,第2代的高容許量定序器現在在全球各國仍為主要產品。中國的DNA定序器市場為外資型企業獨佔,一般認為今後也將暫時持續這個狀態,不過國內企業也可觀察到獨自開發第2代定序器,及企業合併、收購(M&A)的經營基礎強化的動向。

本報告提供全球及中國的DNA定序器產業相關分析、DNA定序器的技術性特性和成本、全球市場規模與結構、企業合併與收購(M&A)的動向、中國國內的產業趨勢、相關政策、市場環境、未來展望、外資與國內主要企業簡介的資訊,為您概述為以下內容。

第1章 DNA定序產業概要

  • 定義
  • 相關產業
  • 應用領域
  • 發展歷史和技術特徵
  • 成本

第2章 全球DNA定序產業

  • 對大企業來說的相關產業的關聯性
  • 主要的企業合併、收購(M&A)
  • 遺傳基因資料庫
  • 定序器
  • 市場規模和其預測

第3章 中國的DNA定序產業

  • 發展
  • 政策環境
  • 市場結構
    • 定序器
    • 服務
  • 未來發展預測

第4章 主要企業

  • Illumina
    • 簡介
    • 經營情形
    • 收益結構
    • 毛利率
    • 研究開發(R&D)及投資
    • DNA定序
    • 今後發展預測
  • Thermo Fisher Scientific
  • BGI
  • Roche
  • Qiagen
  • Pacific Biosciences
  • Sequenom
  • DAAN Gene
  • Agilent Technologies
  • Berry Genomics
  • Hunan China Sun Pharmaceutical Machinery
  • Jilin Zixin Pharmaceutical Industrial

圖表一覽

目錄
Product Code: PQ015

DNA sequencing is the process of reading nucleotide bases in a specific DNA molecule, that is to say determining the arrangement mode of adenine, thymine, cytosine, and guanine. It can be applied in a broad range of fields, including medicine, biology, geology, and agriculture.

With the advancement of DNA sequencing technology and dramatic decline in sequencing costs, DNA sequencing is increasingly showing its market potential in noninvasive detection, disease diagnosis, and personalized treatment. In 2013, the market size of global DNA sequencing (including equipment and consumables, service and workflow, etc.) approximated USD4.6 billion, up around 26% from the previous year. It is projected that by 2017 this figure will reach USD10.096 billion, exceeding USD10 billion for the first time.

Ever since 1975, DNA sequencing technology has been through four generations, but the fourth-generation technology-Nanopore sequencing is still under development. Due to technologies and costs, the second-generation high-throughput sequencers are the mainstream sequencing platform around the world, with its total number occupying over 95% of next-generation DNA sequencers worldwide.

The upstream sectors of DNA sequencing industry are extremely robust, with the global market dominated by the second-generation DNA sequencing enterprises including Illumina, Thermo Fisher Scientific (through Life Technologies), Roche and the third-generation sequencing enterprises such as Pacific Biosciences. A review of these giants' development history shows that mergers and acquisitions are the main driving forces behind the great market power. In February 2014, Roche acquired Life Technologies for USD13.6 billion, making it the industry giant second only to Illumina.

In China, the upstream sectors of DNA sequencing industry are virtually monopolized by foreign giants. BGI is the leader in China's DNA sequencing service, and its second-generation DNA sequencers top the global chart in number. However, two of its sequencers-HiSeq 2000 and Ion Proton were entirely from Illumina and Life Technologies. In March 2013, BGI acquired Complete Genomics, a sign that BGI formally ventured into the upstream sectors of DNA sequencing industry. In June 2014, BGI's two products-BGISEQ-1000 and BGISEQ-100 became the first second-generation DNA sequencers registered in China.

It is expected, however, that within the next five years the weak position of Chinese enterprises in upstream sectors will remain unchanged except for the epic M&A.

‘Global and China DNA Sequencing Industry Research Report, 2014-2017’ mainly focuses on the followings:

  • Features, cost, etc. of DNA sequencing technology;
  • Major M&As, genetic database, market size and structure, etc. of global DNA sequencing industry;
  • Development, industry policies, market structure and prospects, etc. of DNA sequencing industry in China;
  • Operation, DNA sequencing business, etc. of 12 enterprises at home and abroad.

Table of Contents

1. Overview of DNA Sequencing Industry

  • 1.1. Definition
  • 1.2. Industry Chain
  • 1.3. Application
  • 1.4. Development History and Technical Features
  • 1.5. Cost

2. Global DNA Sequencing Industry

  • 2.1. Industry Chain Layout of Major Enterprises
  • 2.2. Major M&As
  • 2.3. Genetic Database
  • 2.4. Sequencer
  • 2.5. Market Size and Prospects

3. China DNA Sequencing Industry

  • 3.1. Development
  • 3.2. Policy Environment
  • 3.3. Market Structure
    • 3.3.1. Sequencer
    • 3.3.2. Service
  • 3.4. Prospects

4. Key Enterprises

  • 4.1. Illumina
    • 4.1.1. Profile
    • 4.1.2. Operation
    • 4.1.3. Revenue Structure
    • 4.1.4. Gross Margin
    • 4.1.5. R&D and Investment
    • 4.1.6. DNA Sequencing
    • 4.1.7. Development Prospects
  • 4.2. Thermo Fisher Scientific
    • 4.2.1. Profile
    • 4.2.2. Operation
    • 4.2.3. Revenue Structure
    • 4.2.4. Operating Margin
    • 4.2.5. R&D and Investment
    • 4.2.6. DNA Sequencing
    • 4.2.7. Development in China
    • 4.2.8. Development Prospects
  • 4.3. BGI
    • 4.3.1. Profile
    • 4.3.2. Operation
    • 4.3.3. DNA Sequencing
  • 4.4. Roche
    • 4.4.1. Profile
    • 4.4.2. DNA Sequencing
  • 4.5. Qiagen
    • 4.5.1. Profile
    • 4.5.2. Operation
    • 4.5.3. Revenue Structure
    • 4.5.4. R&D
    • 4.5.5. DNA Sequencing
  • 4.6. Pacific Biosciences
    • 4.6.1. Profile
    • 4.6.2. Operation
    • 4.6.3. Revenue Structure
    • 4.6.4. R&D
    • 4.6.5. DNA Sequencing
  • 4.7. Sequenom
    • 4.7.1. Profile
    • 4.7.2. Operation
    • 4.7.3. Revenue Structure
    • 4.7.4. Operating Margin
    • 4.7.5. R&D
    • 4.7.6. DNA Sequencing
  • 4.8. DAAN Gene
    • 4.8.1. Profile
    • 4.8.2. Operation
    • 4.8.3. Revenue Structure
    • 4.8.4. Gross Margin
    • 4.8.5. R&D
    • 4.8.6. DNA Sequencing
    • 4.8.7. Development Prospects
  • 4.9. Agilent Technologies
    • 4.9.1. Profile
    • 4.9.2. Operation
    • 4.9.3. Revenue Structure
    • 4.9.4. R&D
    • 4.9.5. DNA Sequencing
  • 4.10. Berry Genomics
    • 4.10.1. Profile
    • 4.10.2. DNA Sequencing
  • 4.11. Hunan China Sun Pharmaceutical Machinery
    • 4.11.1. Profile
    • 4.11.2. DNA Sequencing
  • 4.12. Jilin Zixin Pharmaceutical Industrial
    • 4.12.1. Profile
    • 4.12.2. Operation
    • 4.12.3. DNA Sequencing

Selected Charts:

  • DNA Sequencing Industry Chain
  • DNA Sequencing Technology Application by Field
  • Features of DNA Sequencing Technology and its Advantage and Disadvantage by Generation
  • Trend in Sequencing Cost per Genome, 2001-2014
  • Trend in Sequencing Cost per Megabase, 2001-2014
  • Industry Chain Distribution of Major Global DNA Sequencing Enterprises
  • Major M&As in Global DNA Sequencing Industry, 2007-2014
  • Trend in The DDBJ Nucleotide Sequence Database, 2002-2014
  • Trend in The DDBJ Nucleotide Sequence Database Structure, 2002-2014
  • Top 30 DDBJ Organisms by Number of Nucleotides as of Mar. 2014
  • Next-generation DNA Sequencing Data of GenBank, 2008-2014
  • Worldwide Top 30 Countries or Regions with Next-generation DNA Sequencer by Number of Centers as of Sept. 2014
  • Global Next-Generation DNA Sequencer Distribution by Center as of Sept. 2014
  • Global Next-Generation DNA Sequencer Market Structure by Product as of Sept. 2014
  • Global Next-Generation DNA Sequencing Market Structure by Enterprise as of Sept. 2014
  • Global Next-Generation DNA Sequencing Market Structure by Number of Generation as of Sept. 2014
  • Global Next-Generation DNA Sequencer Distribution by Region as of Sept. 2014
  • Worldwide Top 30 Countries or Regions by Number of Next-Generation DNA Sequencers as of Sept. 2014
  • Next-Generation DNA Sequencer Market Structure of Global Genome Centers by Product as of Sept. 2014
  • Top 10 Global Genome Centers by Number of Next-Generation DNA Sequencers as of Sept. 2014
  • Global DNA Sequencing Market Size and YoY Growth, 2009-2017E
  • Global DNA Sequencing Market Structure by Type, 2013
  • Global DNA Sequencing Market Structure, 2017E
  • Global DNA Sequencing Target Market Potential
  • Policies on China DNA Sequencing industry, 2012-2014
  • China Next-generation DNA Sequencer Proportion in Global Market as of Sept. 2014
  • Revenue and Net Income of Illumina, 2007-2014
  • Revenue Structure of Illumina by Business, 2007-2013
  • Revenue Breakdown of Illumina by Region, 2007-2013
  • Gross Margin Trends of Illumina, 2007-2014
  • R&D Costs and % of Total Revenue of Illumina, 2007-2014
  • Illumina's M&A History, 2007-2014
  • Illumina's DNA Sequencers and Consumables (by Type) and Their Application
  • Revenue and Net Income of Illumina, 2014-2017E
  • Revenue and Net Income of Thermo Fisher Scientific, 2009-2014
  • Revenue Breakdown of Thermo Fisher Scientific by Business, 2009-2014
  • Revenue Breakdown of Thermo Fisher Scientific by Region, 2010-2013
  • Operating Margin of Thermo Fisher Scientific by Business, 2009-2014
  • R&D Costs and % of Total Revenue of Thermo Fisher Scientific, 2009-2014
  • Revenue and YoY Growth of Life Technologies, 2009-2013
  • Revenue and YoY Growth of Thermo Fisher Scientific in China, 2009-2013
  • Revenue and Net Income of Thermo Fisher Scientific, 2014-2017E
  • Revenue and YoY Growth of BGI, 2007-2013
  • Events of BGI's DNA Sequencing Industry Layout, 1999-2014
  • Roche's Revenue from Molecular Diagnosis and % of Total Revenue, 2009-2014
  • Roche's Newly-released DNA Sequencing Products, 2012-2013
  • Revenue and Net Income of Qiagen, 2009-2014
  • Revenue Breakdown of Qiagen by Business, 2009-2014
  • Revenue Structure of Qiagen by Application, 2011-2014
  • Revenue Breakdown of Qiagen by Region, 2009-2013
  • R&D Costs and % of Total Revenue of Qiagen, 2009-2014
  • Revenue and Net Income of Pacific Biosciences, 2009-2014
  • Revenue Breakdown of Pacific Biosciences by Region, 2009-2013
  • R&D Costs and % of Total Revenue of Pacific Biosciences, 2009-2014
  • Pacific Biosciences' Revenue from DNA Sequencing by Product, 2011-2014
  • Revenue and Net Income of Sequenom, 2009-2014
  • Revenue Breakdown of Sequenom by Segment, 2009-2014
  • Revenue Breakdown of Sequenom by Region, 2009-2013
  • Operating Margin of Sequenom by Segment, 2009-2014
  • R&D Costs and % of Total Revenue of Sequenom, 2009-2014
  • Sequenom's Revenue from Gene Analysis by Segment, 2010-2013
  • Revenue and Net Income of DAAN Gene, 2009-2014
  • Revenue Breakdown of DAAN Gene by Business, 2009-2014
  • Revenue Breakdown of DAAN Gene by Region, 2009-2014
  • Gross Margin of DAAN Gene by Business, 2009-2014
  • R&D Costs and % of Total Revenue of DAAN Gene, 2009-2014
  • Revenue and Net Income of Agilent Technologies, FY2009-FY2014
  • Revenue Breakdown of Agilent Technologies by Business, FY2011-FY2014
  • Revenue Breakdown of Agilent Technologies by Region, FY2011-FY2013
  • R&D Costs and % of Total Revenue of Agilent Technologies, 2009-2014
  • Revenue and Net Income of DAAN Gene, 2014-2017E
  • Major Events of Berry Genomics, 2010-2014
  • DNA Sequencing Products of Berry Genomics
  • Revenue and Net Income of Hunan Honghao Gene, 2012-2014
  • Hunan Honghao Gene's Medical Devices Registered Based on Gene Chip, 2012-2014
  • Revenue and Net Income of Jilin Zixin Pharmaceutical Industrial, 2009-2014
  • Development History of DNA Sequencing of Jilin Zixin Pharmaceutical Industrial, 2010-2014
Back to Top